Use of androgens in hematologic disease.
D000328:Adult; D000728:Androgens / Q000009:adverse effects / Q000627:therapeutic use*; D000731:Androstanes / Q000009:adverse effects / Q000627:therapeutic use; D000743:Anemia, Hemolytic / Q000188:drug therapy; D001855:Bone Marrow Diseases / Q000188:drug therapy; D002648:Child; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000096:biosynthesis; D005260:Female; D006130:Growth Disorders / Q000139:chemically induced; D006402:Hematologic Diseases / Q000188:drug therapy*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D008297:Male; D014770:Virilism / Q000139:chemically induced
D000728:Androgens; D000731:Androstanes; D004921:Erythropoietin